Marc R. Viscogliosi​

Principal

Marc Viscogliosi is an experienced CEO, Venture & Private Equity Investor and Company/Industry Creator with a proven track record of success in the medical device industry over the past two decades.

Throughout his 20-year career, Mr. Viscogliosi has completed over $800 million in equity and debt capital raises at all levels of a company’s lifecycle, while generating over $2.2 billion in exit values for investor-partners and stakeholders. With over a dozen issued medical device patents, several FDA PMA Approvals and leading products through the AMA CPT Coding and Payer Coverage Policy development processes, Mr. Viscogliosi has consistently shepherded start-ups into high-growth, high-performance organizations.

In 1999, Mr. Viscogliosi, with his brothers Anthony and John, co-founded Viscogliosi Brothers, LLC (“VB”), a merchant bank focused on investing its own capital, alongside that of its partners, as direct investments into musculoskeletal companies. VB and its partners have invested over $800 million in combined equity and debt financings in 20 companies that have resulted in 15 exits and $2.2 billion in distributable proceeds. These exits have included trade sales to Johnson & Johnson DePuy Synthes, Stryker Corp., Zimmer Biomet, Inc., Abbot, Globus Medical, Inc., RTI Surgical, Inc., and Alphatec Spine, Inc.  Mr. Viscogliosi has founded and led several musculoskeletal companies, including Paradigm Spine and Knee Creations. 

Mr. Viscogliosi began his career as a Wall Street institutional equity sell-side research analyst, covering the neuro-musculoskeletal industry from 1992 to 1999. He holds a B.A. from New York University with a double-major in Economics and Political Science.

Mr. Viscogliosi is passionate about clinical and regulatory strategies, intellectual property development and strategic commercial access market opportunities.​